Menu

Notable Science Quotes

The importance of science innovation, publishing and gender, and more

Dec 1, 2016
The Scientist Staff

SCIENCE ADVOCATE IN CHIEF: President Barack Obama chats with entrants Evan Jackson, Alec Jackson, and Caleb Robinson from Flippen Elementary School in McDonough, Georgia, at the 2013 White House Science Fair.WHITE HOUSE/CHUCK KENNEDY/WIKIMEDIA COMMONS

We must keep funding scientific, technological, and medical research. And above all, we must embrace that quintessentially American compulsion to race for new frontiers and push the boundaries of what’s possible. If we do, I’m hopeful that tomorrow’s Americans will be able to look back at what we did—the diseases we conquered, the social problems we solved, the planet we protected for them—and when they see all that, they’ll plainly see that theirs is the best time to be alive.

—President Barack Obama writing in the November issue of Wired about the importance of science innovation (October 12)

 

Presidents have power over the direction of scientific research on a very large scale, which is an important factor for voters to consider when making their choices for elected officials.

Susannah Gal, Penn State Harrisburg associate dean for research and outreach, on the impact a newly elected president can have on the direction of the US research enterprise (November 1)

 

So publishing more papers is like buying more tickets. And that’s why you have a bigger impact during your more productive years.

—Statistical physicist Roberta Sinatra of Central European University in Budapest who coauthored a recently published Science paper that reported an analysis of more than 500,000 studies across multiple fields and suggested that dumb luck plays a big role in citation impact (November 3)

 

Our present analysis conclusively shows that females do have fewer distinct coauthors over their careers, but that this gap can be accounted for by differences in number of publications. We also find evidence for the hypothesis that female scientists are more open to novel collaborations than their male counterparts, a behavior that was shown to correlate with producing work of greater impact.

X.H.T. Zeng et al., authors of a recently published PLOS Biology paper that analyzed collaboration patterns by considering the publication records of nearly 4,000 faculty members from a variety of scientific disciplines (November 4)

 

I’m just trying to save people’s lives, and now I’m being thrown into this abortion fight as a proxy. I have nothing to do with abortion, I don’t encourage abortion—I just use tissue that would otherwise be discarded. And now I’m painted as this “baby killer” just for doing research as a medical student.

Eugene Gu, a Vanderbilt University surgical resident who was the first to successfully transplant the (legally obtained) heart and kidney of a human fetus into a rat, on the Congressional investigation of his company, Ganogen (The Huffington Post, November 3)

 

Ralph Cicerone was a model for all of us of not only doing what counts, but doing it with honesty, integrity, and deep passion.

Marcia McNutt, president of the National Academy of Sciences, remembering her predecessor, who died last month at the age of 73 (November 7)
 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.